Last reviewed · How we verify
NCT03957512
Livet Skal Leves (A Life to Live)
trial testing Heart surgery in Heart Defects, Congenital in 3,000 participants. Completed in 31 December 2018.
31 December 2017
Quick facts
| Lead sponsor | Oslo University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 3,000 |
| Start date | 1 October 2017 |
| Primary completion | 31 December 2017 |
| Estimated completion | 31 December 2018 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Heart surgery
Conditions studied
- Heart Defects, Congenital — all drugs for Heart Defects, Congenital →
Sponsor
Oslo University Hospital
Who can join
Under 2, any sex, with Heart Defects, Congenital. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall objective of this project is to optimize the use of diagnostic methods and follow-up programs in infants with congenital heart defects (CHDs) in order to reduce death and complications
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03957512
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Heart surgery
Trials testing the same drug.
- NCT06088823 — Paresthesia in Hand and Antebrachium Following CardiacSurgery: Incidence, Risk Factors and Clinical Course · completed
Other recruiting trials for Heart Defects, Congenital
Currently open trials in the same condition.
- NCT06003023 — Congenital Heart Disease Physical Activity Lifestyle Study V.2 · NA · recruiting
- NCT05709470 — Mind the Heart - Mental Health in Children and Adolescents With Congenital Heart Defects · recruiting
- NCT05330338 — Genetics of Ventriculo-arterial Discordance · NA · active not recruiting
- NCT06089902 — European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries · recruiting
Other Oslo University Hospital trials
Trials by the same sponsor.
- NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
- NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
- NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
- NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
- NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03957512 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
- Last refreshed: 22 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957512.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing